AzTrials
AzTrials

Respiratory InsufficiencyNCT02358460

Pressure-limited Ventilation Versus Volume-targeted Ventilation in Term Newborns

A study testing Ventilation delivered by SLE5000 ventilator in people with Respiratory Insufficiency, run by King's College London at 2 sites in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

A randomised controlled trial comparing volume-targeted ventilation to pressure-limited ventilation in infants born at or near term. Read more about this study

Who is it for?
Ages 1 minute to 4 weeks
Conditions the study is for
Respiratory Insufficiency
What is being tested?
Ventilation delivered by SLE5000 ventilator
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
2 sitesUnited Kingdom
Study dates
May 2011to Sep 2014
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 minute to 4 weeks
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Mechanically ventilated
  • Born at gestation 34 weeks and above

Who cannot join

  • Congenital diaphragmatic hernia
  • Congenital heart disease

Trial locations and contacts

2 sites in 1 country.

United Kingdom2 sites
  • King's College Hospital NHS Foundation Trust

    London, London, SE5 9RS

  • Neonatal Intensive Care Unit

    London, SE5 9RS

Other trials in United Kingdom

About this study

Official title: Randomised Controlled Trial Comparing Volume-targeted to Pressure-limited Ventilation in Infants Born at or Near Term

A randomised controlled trial comparing volume-targeted ventilation to pressure-limited ventilation in infants born at or near term.

Read the detailed description

Aims: There is increasing evidence that volume-targeted ventilation (VTV) holds benefits for preterm infants in comparison to pressure-limited ventilation. It is not known whether the same is true in the case of infants born at term. This study aims to compare pressure-limited to VTV in term-born infants.

Hypothesis: Volume-targeted will be associated with significantly earlier extubation compared to pressure-limited ventilation Primary outcome: Time to extubation. Methods: Ventilated infants 34 weeks or more gestational age at birth were recruited and randomly allocated to receive either pressure-limited or VTV. Adjustments to ventilator settings were made according to the trial protocol. Infants were deemed to have met failure criteria if they required HFOV or peak pressures of more than 30 cm of water. Analysis will be by intention-to-treat.

Being tested
Ventilation delivered by SLE5000 ventilator
Keywords
neonatal, respiratory, mechanical ventilation
Medical subject headings
Respiratory Insufficiency

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ventilation delivered by SLE5000 ventilatorDevice

    In pressure-limited ventilation arm, ventilator settings as required to maintain appropriate oxygenation and carbon-dioxide elimination.

    In volume-targeted ventilation arm, set target volume at 5ml/kg and wean rate. In both arms, aim to keep blood gases within normal limits.

Study groups in NCT02358460
Study groupRoleWhat they receive
Pressure-limited ventilationActive comparatorNot described
Receives: Device: Ventilation delivered by SLE5000 ventilator
Volume-targeted ventilationActive comparatorNot described
Receives: Device: Ventilation delivered by SLE5000 ventilator

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Duration of mechanical ventilation

    Data will be collected from the intensive care observation chart to determine the time at which the infant was successfully taken off of mechanical ventilation, assessed up to 4 weeks.

    Measured: For each patient, the exact number of hours from the date and time of randomisation to the date and time of successful removal of the endotracheal tube, assessed up to 4 weeks.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Feb 2015 (estimated)
  2. Study startMay 2011
  3. Primary completionSep 2014
  4. Study completionSep 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02358460
Sponsor's protocol ID
07/H0808/147-3
Status last verified
Feb 2015
First submitted
13 Jan 2015
Last updated
9 Feb 2015
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Ventilation delivered by SLE5000 ventilator in people with Respiratory Insufficiency, run by King's College London at 2 sites in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Feb 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Duration of mechanical ventilation (time frame: For each patient, the exact number of hours from the date and time of randomisation to the date and time of successful removal of the endotracheal tube, assessed up to 4 weeks.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Feb 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in